GSK plc (GLAXF) revenue by segment

GLAXFOTCPharmaceutical PreparationsAlso trades as GSK

Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30

$24.74+0.30 (+1.21%)

Close on Oct 19, 2026Market cap $53.38BP/E 6.7Yield –

GSK plc revenue by segment

GSK does not break out revenue by segment, region or product in the tagged data of its filings for this period type.